2023 - Research.com Medicine in Spain Leader Award
Stroke, Internal medicine, Vascular disease, Pathology and Surgery are her primary areas of study. Her work deals with themes such as Tissue plasminogen activator, Transcranial Doppler and Ischemia, which intersect with Stroke. As part of her studies on Internal medicine, Joan Montaner often connects relevant subjects like Cardiology.
Her Vascular disease study combines topics in areas such as Anesthesia, Central nervous system disease, Prospective cohort study, Risk factor and C-reactive protein. Her biological study spans a wide range of topics, including Human brain, Matrix metalloproteinase, Blood–brain barrier and Edema. Her research in Surgery intersects with topics in Placebo, Clinical trial, Ischemic stroke and Neurology.
Joan Montaner spends much of her time researching Stroke, Internal medicine, Cardiology, Pathology and Surgery. She combines subjects such as Vascular disease and Ischemia with her study of Stroke. Her Vascular disease research includes themes of Prospective cohort study and Central nervous system disease.
Joan Montaner regularly links together related areas like Gastroenterology in her Internal medicine studies. Her Cardiology research incorporates themes from Neurology, Magnetic resonance imaging and Physical therapy. Her research investigates the link between Thrombolysis and topics such as Middle cerebral artery that cross with problems in Occlusion.
Her primary areas of investigation include Internal medicine, Stroke, Cardiology, Biomarker and Ischemic stroke. Her Internal medicine research integrates issues from Gastroenterology and Neurology. Her study in Stroke is interdisciplinary in nature, drawing from both Pneumonia, Asymptomatic, Radiology, Ischemia and Subarachnoid hemorrhage.
Joan Montaner has researched Cardiology in several fields, including Diabetes mellitus and Acute ischemic stroke. The concepts of her Biomarker study are interwoven with issues in CADASIL, Oncology and In situ hybridization. Joan Montaner works mostly in the field of Ischemic stroke, limiting it down to topics relating to Genome-wide association study and, in certain cases, Locus.
Joan Montaner mainly investigates Internal medicine, Stroke, Cardiology, Confidence interval and Pneumonia. She regularly ties together related areas like Diabetes mellitus in her Internal medicine studies. Her Stroke study incorporates themes from Proteomics, Biomarker discovery, Ischemia, Atrial fibrillation and Cohort.
The study incorporates disciplines such as Magnetic resonance imaging, Neurology, Asymptomatic and Ischemic stroke in addition to Cardiology. Her study looks at the intersection of Pneumonia and topics like Antibiotics with Intensive care medicine, Etiology and Retrospective cohort study. Her Intracerebral hemorrhage study integrates concerns from other disciplines, such as Glial fibrillary acidic protein and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.
Andrei V. Alexandrov;Andrei V. Alexandrov;Carlos A. Molina;James C. Grotta;Zsolt Garami.
The New England Journal of Medicine (2004)
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage
Thorsten Steiner;Rustam Al-Shahi Salman;Ronnie Beer;Hanne Christensen.
International Journal of Stroke (2014)
Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke
Joan Montaner;Carlos A. Molina;Jasone Monasterio;Sonia Abilleira.
MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke
Anna Rosell;Eloy Cuadrado;Arantxa Ortega-Aznar;Mar Hernández-Guillamon.
Microbubble Administration Accelerates Clot Lysis During Continuous 2-MHz Ultrasound Monitoring in Stroke Patients Treated With Intravenous Tissue Plasminogen Activator
Carlos A. Molina;Marc Ribo;Marta Rubiera;Joan Montaner.
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.
Matthew Traylor;Martin Farrall;Elizabeth G Holliday;Cathie Sudlow.
Lancet Neurology (2012)
Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke
Anna Rosell;Arantxa Ortega-Aznar;José Alvarez-Sabín;Israel Fernández-Cadenas.
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Joan Montaner;José Alvarez-Sabín;Carlos Molina;Ana Anglés.
Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients
José Alvarez-Sabín;Carlos A. Molina;Joan Montaner;Juan F. Arenillas.
Molecular signatures of brain injury after intracerebral hemorrhage
J. Castillo;A. Davalos;J. Alvarez-Sabin;J. M. Pumar.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: